Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

VERACYTE, INC. Director's Dealing 2021

Mar 4, 2021

31551_dirs_2021-03-04_00dace1d-650a-4a06-816d-ae8d0c419e5e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VERACYTE, INC. (VCYT)
CIK: 0001384101
Period of Report: 2021-03-02

Reporting Person: Kennedy Giulia C (Chief Scientific & Med Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-03-02 Common Stock F 5995 $62.15 Disposed 74769 Direct

Footnotes

F1: The reporting person is reporting the withholding of 292, 248, 3,967 and 1,488 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 588, 500, 8,000 and 3,000 Restricted Stock Units, respectively, granted on March 2, 2018, February 28, 2019, February 28, 2019 and February 28, 2020 respectively, and does not represent a saleby the reporting person.